Progressive cardiac failure following orthotopic liver transplantation for type IV glycogenosis.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 1601012)

Published in Eur J Pediatr on March 01, 1992

Authors

E M Sokal1, F Van Hoof, D Alberti, J de Ville de Goyet, T de Barsy, J B Otte

Author Affiliations

1: Department of Paediatrics, Université Catholique de Louvain, Hôpital St. Luc, Brussels, Belgium.

Articles by these authors

Commentary. Lysosomotropic agents. Biochem Pharmacol (1974) 12.28

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46

Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58

The abnormalities of lysosomal enzymes in mucopolysacc- haridoses. Eur J Biochem (1968) 2.55

Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients. Ann Surg (1984) 2.31

Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients. Transpl Int (1997) 2.14

Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol (1990) 2.06

Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99

Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein. Dig Dis Sci (1993) 1.94

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet (1991) 1.82

Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet (1987) 1.68

IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem (1997) 1.67

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer. J Clin Oncol (1994) 1.67

Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr (1999) 1.61

Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer (2004) 1.60

Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol (1982) 1.58

Mucopolysaccharidosis by absence of alpha-fucosidase. Lancet (1968) 1.56

Liver transplantation in children less than 1 year of age. J Pediatr (1990) 1.55

The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54

Progressive familial myoclonic epilepsy with Lafora bodies. Electron microscopic and histochemical study of a cerebral biopsy. Acta Neuropathol (1967) 1.51

Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology (1991) 1.51

Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg (1990) 1.50

The wandering spleen. Eur J Pediatr (1983) 1.48

Endoscopic stapling technique of esophagodiverticulostomy for Zenker's diverticulum. Ann Thorac Surg (1993) 1.47

Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation (1993) 1.47

Liver transplantation and pulmonary gas exchanges in hypoxemic children. Am Rev Respir Dis (1993) 1.45

Retroperitoneal laparostomy: a surgical treatment of pancreatic abscesses after an acute necrotizing pancreatitis. Surgery (1992) 1.43

Laparoscopic treatment of gallbladder duplication. A plea for removal of both gallbladders. Surg Endosc (1997) 1.43

Isolated liver transplant in infants with short bowel syndrome: insights into outcomes and prognostic factors. J Pediatr Gastroenterol Nutr (2009) 1.42

The concept and technique of the split liver in clinical transplantation. Surgery (1990) 1.41

[Liver transplantation in familial amyloidosis]. Dtsch Med Wochenschr (1995) 1.41

Fluvoxamine: an antidepressant with low (or no) epileptogenic effect. Lancet (1990) 1.39

Standardized quick en bloc technique for procurement of cadaveric liver grafts for pediatric liver transplantation. Transpl Int (1995) 1.38

Adult-to-adult living related liver transplantation: initial experience. Acta Gastroenterol Belg (2001) 1.37

Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst (1997) 1.35

Pseudo-Zellweger syndrome: deficiencies in several peroxisomal oxidative activities. J Pediatr (1986) 1.35

Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis. Eur J Biochem (1972) 1.30

Esophageal replacement: gastric tube or whole stomach? Ann Thorac Surg (1995) 1.30

A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28

Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension. J Pediatr Surg (1998) 1.27

Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg (1998) 1.27

Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Quantitative ultrastructural and biochemical study. Lab Invest (1979) 1.26

Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol (1973) 1.24

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22

Gentamicin-induced nephrotoxicity: a cell biology approach. Kidney Int (1980) 1.22

Laparoscopic antireflux surgery. What is real progress? Ann Surg (1994) 1.21

Impact of innovative techniques on the waiting list and results in pediatric liver transplantation. Transplantation (1993) 1.20

Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency. Biochem J (1975) 1.20

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol (1994) 1.18

The denervated stomach as an esophageal substitute is a contractile organ. Ann Surg (1998) 1.17

Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr (1987) 1.17

Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16

The effect of isoproterenol and Collins' solution on the preservation of canine livers with simple cooling. Transplant Proc (1974) 1.16

Hirschsprung's disease: a 20-year experience. J Pediatr Surg (1997) 1.15

Laparoscopic splenectomy in adults and children: experience with 31 patients. Surgery (1996) 1.15

Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int (1998) 1.14

Infantile form of sialic acid storage disorder: clinical, ultrastructural, and biochemical studies in two siblings. Eur J Pediatr (1982) 1.13

Unusual evolution of an Epstein-Barr virus-associated leiomyosarcoma occurring after liver transplantation. Pediatr Transplant (2001) 1.12

Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol (2002) 1.10

Psychological and social adjustment after pediatric liver transplantation as a function of age at surgery and of time elapsed since transplantation. Pediatr Transplant (1997) 1.09

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation (1997) 1.09

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer (2013) 1.08

Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant (1996) 1.07

Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant. Transplantation (1992) 1.06

Acid maltase deficiency in non-identical adult twins. A morphological and biochemical study. J Neurol (1976) 1.06

The subgroups of type 3 glycogenosis. Eur J Biochem (1967) 1.05

Anesthesia for pediatric hepatic transplantation: experience of 33 cases. Transplant Proc (1987) 1.05

Indication, technique, and results of liver graft volume reduction before orthotopic transplantation in children. Transplant Proc (1987) 1.05

Original extrahilar approach for hepatic portal revascularization and relief of extrahepatic portal hypertension related to later portal vein thrombosis after pediatric liver transplantation. Long term results. Transplantation (1996) 1.05

Pediatric liver transplantation: report on 52 patients with a 2-year survival of 86%. J Pediatr Surg (1988) 1.04

Arterialization of the portal vein in conjunction with a therapeutic portacaval shunt. Hemodynamic investigations and results in 75 patients. Ann Surg (1982) 1.04

Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur Radiol (2000) 1.03

Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology (1996) 1.03

Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. Biochem J (1984) 1.03

Sequential treatment of biliary atresia with Kasai portoenterostomy and liver transplantation: a review. Hepatology (1994) 1.02

Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Am J Med Genet (1997) 1.02

Recent developments in pediatric liver transplantation. Transplant Proc (1987) 1.02

Skeletonizing en bloc esophagectomy for cancer. Ann Surg (2001) 1.01

On an autosomal dominant form of retinal-cerebellar degeneration: an autopsy study of five patients in one family. Acta Neuropathol (1994) 1.01

Diverticulum formation after circular myotomy for esophageal atresia. J Pediatr Surg (1984) 1.01

Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: a new physiological procedure. Eur J Surg (1999) 1.00

Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy. J Pediatr Gastroenterol Nutr (1993) 1.00

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function. Kidney Int (1990) 1.00

Simplified technique of orthotopic liver transplantation in pigs. Transplantation (2001) 0.99

The microsomal dicarboxylyl-CoA synthetase. Biochem J (1985) 0.99

En bloc and standard esophagectomies by thoracoscopy. Ann Thorac Surg (1993) 0.99

Liver transplantation in children: report of 2 1/2 years' experience at the University of Louvain Medical School in Brussels. Transplant Proc (1987) 0.98

Hepatic artery thrombosis in pediatric liver transplantation. J Pediatr Surg (1988) 0.97